Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)
Malaysia · Delayed Price · Currency is MYR 0.2650
0.00 (0.00%)
At close: Jun 3, 2026
KLSE:MGRC Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 9.33 | 8.02 | 5.52 | 9.57 | 8.36 | 28.36 | |
Revenue Growth (YoY) | 83.00% | 45.29% | -42.32% | 14.47% | -70.51% | 1490.09% |
Cost of Revenue | 2.76 | 2.9 | 2.1 | 3.98 | 3.26 | 14.51 |
Gross Profit | 6.57 | 5.13 | 3.42 | 5.59 | 5.1 | 13.85 |
Selling, General & Admin | 5.44 | 5.87 | 7.99 | 25.51 | 11.12 | 7.83 |
Operating Expenses | 6.96 | 7.39 | 8.11 | 25.51 | 18.65 | 7.83 |
Operating Income | -0.39 | -2.27 | -4.69 | -19.92 | -13.55 | 6.02 |
Interest Expense | -0.09 | -0.1 | -0.12 | -0.1 | -0.1 | -0.1 |
Other Non Operating Income (Expenses) | 0.11 | 0.09 | 0.29 | 0.03 | 0.06 | 0.26 |
EBT Excluding Unusual Items | -0.37 | -2.28 | -4.51 | -20 | -13.59 | 6.18 |
Asset Writedown | -0.21 | -0.21 | - | - | - | - |
Pretax Income | -0.58 | -2.49 | -4.51 | -20 | -13.59 | 6.18 |
Income Tax Expense | 0.31 | 0.31 | 0 | 1.15 | 1.15 | -1.03 |
Earnings From Continuing Operations | -0.89 | -2.8 | -4.51 | -21.15 | -14.74 | 7.21 |
Net Income to Company | -0.89 | -2.8 | -4.51 | -21.15 | -14.74 | 7.21 |
Minority Interest in Earnings | 0.4 | 0.42 | 0.32 | 2.1 | 0.5 | 0 |
Net Income | -0.49 | -2.38 | -4.19 | -19.05 | -14.25 | 7.21 |
Net Income to Common | -0.49 | -2.38 | -4.19 | -19.05 | -14.25 | 7.21 |
Shares Outstanding (Basic) | 139 | 137 | 137 | 161 | 128 | 123 |
Shares Outstanding (Diluted) | 139 | 137 | 137 | 161 | 128 | 123 |
Shares Change (YoY) | 1.33% | - | -14.93% | 26.44% | 3.69% | 14.37% |
EPS (Basic) | -0.00 | -0.02 | -0.03 | -0.12 | -0.11 | 0.06 |
EPS (Diluted) | -0.00 | -0.02 | -0.03 | -0.12 | -0.11 | 0.06 |
Free Cash Flow | 0.88 | 1.03 | -0.95 | -17.04 | -22.51 | -1.27 |
Free Cash Flow Per Share | 0.01 | 0.01 | -0.01 | -0.11 | -0.18 | -0.01 |
Gross Margin | 70.45% | 63.89% | 61.98% | 58.39% | 60.98% | 48.84% |
Operating Margin | -4.19% | -28.26% | -84.87% | -208.08% | -162.05% | 21.24% |
Profit Margin | -5.29% | -29.68% | -75.90% | -198.96% | -170.32% | 25.42% |
Free Cash Flow Margin | 9.44% | 12.88% | -17.12% | -177.98% | -269.11% | -4.49% |
EBITDA | 0.69 | -1.18 | -3.49 | -18.57 | -12.19 | 6.82 |
EBITDA Margin | 7.40% | -14.70% | -63.22% | -193.96% | -145.73% | 24.05% |
D&A For EBITDA | 1.08 | 1.09 | 1.2 | 1.35 | 1.37 | 0.8 |
EBIT | -0.39 | -2.27 | -4.69 | -19.92 | -13.55 | 6.02 |
EBIT Margin | -4.19% | -28.26% | -84.87% | -208.08% | -162.05% | 21.24% |